Part 2/8:
Currently trading at around $58 per share, Teladoc was previously priced at $86, making its recent decrease noteworthy. Todd Campbell, an investor who has expressed interest in Teladoc, recently purchased shares during this period of weakness. While holding a small position of 2% of his portfolio, he believes that the long-term growth potential justifies the investment. The company, with a market cap of about $4 billion, reported third-quarter sales that surged 62% year over year, amounting to $111 million.